Application
Western blot analysis of extracts from Jurkat cells, treated with etoposide 25uM 24h, using CD97 beta (Cleaved-Ser531) Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | CD97 beta (cleaved Ser531) antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to CD97 beta (cleaved Ser531)Receptor potentially involved in both adhesion and signaling processes early after leukocyte activation. Plays an essential role in leukocyte migration. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human CD97 beta. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAWB |
| ELISA: 1:5000Optimal dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | CD97 beta (cleaved S531) CD97 beta (cleaved Ser531) CD97 beta cleaved S531 CD97 beta cleaved Ser531 Cleaved CD97 beta (S531) Cleaved CD97 beta (Ser531) |
|---|---|
| Target | CD97 beta |
| Molecular Weight(MW) | 92 and 36 kDa (note) |
| Tissue Specificity | CD97 beta (Cleaved-Ser531) Antibody detects endogenous levels of fragment of activated CD97 beta resulting from cleavage adjacent to Ser531. |
Application
Western blot analysis of extracts from Jurkat cells, treated with etoposide 25uM 24h, using CD97 beta (Cleaved-Ser531) Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | ELISA: 1:5000Optimal dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
